Long-term outcome of infliximab therapy is highly comparable in a Danish and in a Hungarian tertiary center

Tamás Molnár First Department of Medicine, University of Szeged, Szeged, HungaryCorrespondence[email protected]

Klaudia Farkas First Department of Medicine, University of Szeged, Szeged, Hungary

Zoltán Szepes First Department of Medicine, University of Szeged, Szeged, Hungary

Ferenc Nagy First Department of Medicine, University of Szeged, Szeged, Hungary

Tibor Wittmann First Department of Medicine, University of Szeged, Szeged, Hungary

References

Teisner AS, Ainsworth MA, Brynskov J. Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experience. Scandinavian Journal of Gastroenterology 2010; Early Online, 1–7.
Web of Science ®Google Scholar
Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005;128:1805–11.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Long-term outcome of infliximab therapy is highly comparable in a Danish and in a Hungarian tertiary center

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Long-term outcome of infliximab therapy is highly comparable in a Danish and in a Hungarian tertiary center

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date